{"id":16669,"type":"page","link":"https:\/\/www.ortaakarsu.net\/?page_id=16669","title":{"rendered":"Lemborexant (Lemboreksant) + Oxcarbazepine (Okskarbazepin)"},"content":{"rendered":"<p>Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"excerpt":{"rendered":"<p>Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"ism_preview":{"drugs":[{"title":"Lemborexant (Lemboreksant)","url":"https:\/\/www.ortaakarsu.net\/?page_id=11829","facts":[{"label":"Active ingredient \/ generic name","value":"lemborexant"},{"label":"ATC code","value":"N05CJ02"}]},{"title":"Oxcarbazepine (Okskarbazepin)","url":"https:\/\/www.ortaakarsu.net\/?page_id=11831","facts":[{"label":"Active ingredient \/ generic name","value":"oxcarbazepine"},{"label":"ATC code","value":"N03AF02"}]}],"record":[{"label":"Record type","value":"Published interaction record"},{"label":"Source record version","value":"Eisai ABD DAYVIGO FDA\/DailyMed tam \u00fcr\u00fcn bilgisi; revizyon 02\/2025"}],"sources":[{"label":"Official prescribing information \/ product-characteristics source","url":"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=7074cb65-77b3-45d2-8e8d-da8dc0f70bfd"}],"reviewed_at":"2026-11-04"},"ism_access":{"required":true,"resource_key":"pair:11770","available":true}}